weight-loss and diet control industry

Page 6 of 10

Regulators are looking into whether weight-loss drugs like Ozempic raise the risk of suicidal thoughts
Health

Regulators are looking into whether weight-loss drugs like Ozempic raise the risk of suicidal thoughts

By Deirdre Hipwell and Bloomberg
December 2, 2023
Weight loss drugs are all the rage.
Health

Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro

By Madison Muller and Bloomberg
December 1, 2023
Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options
Newsletters

Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options

By
November 29, 2023
Lars Fruergaard Jorgensen holding a microphone in one hand and paper flashcards in the other hand
Health

Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs

By
November 27, 2023
So many Americans are using Novo Nordisk’s blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug
Retail

So many Americans are using Novo Nordisk’s blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug

By
November 16, 2023
Novo Nordisk employees who need to lose weight get an unusual perk—free Wegovy that normally costs $4,400 annually
Health

Novo Nordisk employees who need to lose weight get an unusual perk—free Wegovy that normally costs $4,400 annually

By Sanne Wass and Bloomberg
November 15, 2023
a box of wegovy injectables
Retail

Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports

By
November 13, 2023
Weight-loss drugs are impacting everything from snack portion sizes to stomach surgery numbers as corporate America adjusts to them
Finance

Weight-loss drugs are impacting everything from snack portion sizes to stomach surgery numbers as corporate America adjusts to them

By
November 13, 2023
Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy
Retail

Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy

By
November 9, 2023
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
Health

Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.

By
November 6, 2023
picture of four wegovy injections lined up
Health

Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze

By
November 3, 2023
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
Health

Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.

By
November 2, 2023
KitKat maker Nestlé working on ‘companion products’ for weight-loss-aiding drugs Ozempic and Wegovy in case shoppers start cutting calories

KitKat maker Nestlé working on ‘companion products’ for weight-loss-aiding drugs Ozempic and Wegovy in case shoppers start cutting calories

By
October 19, 2023
Eli Lilly
Health

New weight-loss blockbuster drug emerges from study showing Mounjaro helps people lose 25% of their body weight or 60 pounds on average

By Jonel Aleccia and The Associated Press
October 15, 2023
ozempic injection picture
Finance

Wall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates

By
October 10, 2023

Most Popular